{"entity":{"type":"insider","cik":"0001280942","url":"/insider/0001280942","json_url":"/insider/0001280942.json","name":"BERK BERNARD","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":30,"n_filings":7,"first":"2004-08-09","last":"2008-01-03","span_basis":"filed_date"},"name_variants":[{"name":"BERK BERNARD","source":"filing","n_filings":7,"first_seen":"2004-08-09","last_seen":"2008-01-03"}],"transactions":[{"id":2650067,"accession":"0000930413-08-000036","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000930413-08-000036","line_url":"/filing/0000930413-08-000036","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELI","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001280942","owner_name":"BERK BERNARD","owner_display_name":"BERK BERNARD","owner_url":"/insider/0001280942","role":"Director, Officer (Chairman, CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman, CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":2.06495,"price_display":"2.06","price_state":"stated","total_value":10324.75,"total_display":"10,324.75","total_whole":"10,325","shares_owned_after":192300.0,"shares_owned_after_display":"192,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-12-31","filed_date":"2008-01-03","scope":"insider","n_lines":2},{"id":7605263,"accession":"0000930413-07-008951","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000930413-07-008951","line_url":"/filing/0000930413-07-008951","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELI","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001280942","owner_name":"BERK BERNARD","owner_display_name":"BERK BERNARD","owner_url":"/insider/0001280942","role":"Director, Officer (CEO and Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12500.0,"shares_display":"12,500","price_per_share":2.03154,"price_display":"2.03","price_state":"stated","total_value":25394.25,"total_display":"25,394.25","total_whole":"25,394","shares_owned_after":189800.0,"shares_owned_after_display":"189,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-21","filed_date":"2007-11-23","scope":"insider","n_lines":3},{"id":7605257,"accession":"0000930413-07-008951","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000930413-07-008951","line_url":"/filing/0000930413-07-008951","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELI","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001280942","owner_name":"BERK BERNARD","owner_display_name":"BERK BERNARD","owner_url":"/insider/0001280942","role":"Director, Officer (CEO and Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":2.218895,"price_display":"2.22","price_state":"stated","total_value":22188.95,"total_display":"22,188.95","total_whole":"22,189","shares_owned_after":177300.0,"shares_owned_after_display":"177,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-20","filed_date":"2007-11-23","scope":"insider","n_lines":3},{"id":1199145,"accession":"0000930413-05-004838","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000930413-05-004838","line_url":"/filing/0000930413-05-004838","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELI","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001280942","owner_name":"BERK BERNARD","owner_display_name":"BERK BERNARD","owner_url":"/insider/0001280942","role":"Director, Officer (Chief Exec. Officer & Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Exec. Officer & Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12000.0,"shares_display":"12,000","price_per_share":3.0766666666666667,"price_display":"3.08","price_state":"stated","total_value":36920.0,"total_display":"36,920.00","total_whole":"36,920","shares_owned_after":167300.0,"shares_owned_after_display":"167,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-07-01","filed_date":"2005-07-05","scope":"insider","n_lines":4},{"id":1290141,"accession":"0000930413-05-004820","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000930413-05-004820","line_url":"/filing/0000930413-05-004820","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELI","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001280942","owner_name":"BERK BERNARD","owner_display_name":"BERK BERNARD","owner_url":"/insider/0001280942","role":"Director, Officer (Chief Exec Officer and Chairmn)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Exec Officer and Chairmn","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":3.01985,"price_display":"3.02","price_state":"stated","total_value":60397.0,"total_display":"60,397.00","total_whole":"60,397","shares_owned_after":155300.0,"shares_owned_after_display":"155,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-06-30","filed_date":"2005-07-01","scope":"insider","n_lines":4},{"id":423477,"accession":"0000930413-04-004847","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000930413-04-004847","line_url":"/filing/0000930413-04-004847#line-1","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELI","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001280942","owner_name":"BERK BERNARD","owner_display_name":"BERK BERNARD","owner_url":"/insider/0001280942","role":"Director, Officer (CEO and Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":70800.0,"shares_display":"70,800","price_per_share":1.25,"price_display":"1.25","price_state":"stated","total_value":88500.0,"total_display":"88,500.00","total_whole":"88,500","shares_owned_after":135300.0,"shares_owned_after_display":"135,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-10-18","filed_date":"2004-10-20","scope":"insider"},{"id":9209916,"accession":"0000930413-04-003571","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000930413-04-003571","line_url":"/filing/0000930413-04-003571","is_derivative":false,"issuer_cik":"0001280942","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELI","issuer_name_source":null,"issuer_url":"/issuer/0001280942","owner_cik":"0001280942","owner_name":"BERK BERNARD","owner_display_name":"BERK BERNARD","owner_url":"/insider/0001280942","role":"Director, Officer (CEO & Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14500.0,"shares_display":"14,500","price_per_share":1.5210344827586206,"price_display":"1.52","price_state":"stated","total_value":22055.0,"total_display":"22,055.00","total_whole":"22,055","shares_owned_after":64500.0,"shares_owned_after_display":"64,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-08-10","filed_date":"2004-08-10","scope":"insider","n_lines":3},{"id":9209913,"accession":"0000930413-04-003571","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000930413-04-003571","line_url":"/filing/0000930413-04-003571","is_derivative":false,"issuer_cik":"0001280942","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELI","issuer_name_source":null,"issuer_url":"/issuer/0001280942","owner_cik":"0001280942","owner_name":"BERK BERNARD","owner_display_name":"BERK BERNARD","owner_url":"/insider/0001280942","role":"Director, Officer (CEO & Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.4167,"price_display":"1.42","price_state":"stated","total_value":14167.0,"total_display":"14,167.00","total_whole":"14,167","shares_owned_after":64500.0,"shares_owned_after_display":"64,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-08-09","filed_date":"2004-08-10","scope":"insider","n_lines":3},{"id":340828,"accession":"0000930413-04-003533","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000930413-04-003533","line_url":"/filing/0000930413-04-003533","is_derivative":false,"issuer_cik":"0001053369","issuer_name":"ELITE PHARMACEUTICALS INC /DE/","issuer_ticker":"ELI","issuer_name_source":null,"issuer_url":"/issuer/0001053369","owner_cik":"0001280942","owner_name":"BERK BERNARD","owner_display_name":"BERK BERNARD","owner_url":"/insider/0001280942","role":"Director, Officer (Chief Exec. Officer & Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Exec. Officer & Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40000.0,"shares_display":"40,000","price_per_share":1.524475,"price_display":"1.52","price_state":"stated","total_value":60979.0,"total_display":"60,979.00","total_whole":"60,979","shares_owned_after":40000.0,"shares_owned_after_display":"40,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-08-05","filed_date":"2004-08-09","scope":"insider","n_lines":7}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":30,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":30,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":30},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001053369","name":"ELITE PHARMACEUTICALS INC /DE/","url":"/issuer/0001053369","role":"Director, Officer (Chairman, CEO and President)","n_filings":7,"first_seen":"2004-08-09","last_seen":"2008-01-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001280942","retrieved_at":"2026-08-23T06:23:57+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}